Down-regulation of cyclic nucleotide phosphodiesterase PDE1A is the key event of p73 and UHRF1 deregulation in thymoquinone-induced acute lymphoblastic leukemia cell apoptosis

被引:60
作者
Abusnina, Abdurazzag [1 ]
Alhosin, Mahmoud [1 ]
Keravis, Therese [1 ]
Muller, Christian D. [2 ]
Fuhrmann, Guy [1 ]
Bronner, Christian [1 ]
Lugnier, Claire [1 ]
机构
[1] Univ Strasbourg, CNRS, Lab Biophoton & Pharmacol, Fac Pharm,UMR 7213, F-67401 Illkirch Graffenstaden, France
[2] Univ Strasbourg, CNRS, Lab Innovat Therapeut, Fac Pharm,UMR 7200, F-67401 Illkirch Graffenstaden, France
关键词
Acute lymphoblastic leukemia; Jurkat cell; Cyclic nucleotide phosphodiesterase; PDE1; Tumor suppressor p73; Epigenetic integrator UHRF1; VASCULAR SMOOTH-MUSCLE; CHRONIC LYMPHOCYTIC-LEUKEMIA; COLORECTAL-CANCER CELLS; HEMI-METHYLATED DNA; JURKAT T-CELLS; AMP PHOSPHODIESTERASE; SPLICE VARIANTS; SRA DOMAIN; INHIBITORS; CAMP;
D O I
10.1016/j.cellsig.2010.08.015
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Thymoquinone (TQ), the active principle of Nigella sativa black seeds, has anti-proliferative properties on numerous cancer cell types. Others and we have previously reported that TQ acts as agent that triggers cell cycle arrest and apoptosis through either a p53- or p73-dependent pathway. However, the immediate targets recruited upon TQ-induced cytotoxicity have not yet been clearly identified. We therefore asked whether cyclic nucleotide phosphodiesterases (PDEs) could be involved in TQ-triggered pro-apoptotic reactivity; PDEs are regulators of intracellular levels of cyclic nucleotides and therefore can modulate cAMP and cGMP-dependent cell death pathways. Our results showed that TQ specifically repressed PDE1A expression in the acute lymphoblastic leukemia Jurkat cell line. This effect is concomitant with the previously described sequential deregulation of the expression of the tumor suppressor protein p73 and the epigenetic integrator UHRF1 (Ubiquitin-like, PHD Ring Finger 1). Interestingly, RNA-interference knock-down of PDE1A expression as well as decreased PDE1A expression induced growth inhibition of Jurkat cells, cell cycle arrest and apoptosis through an activation of p73 and a repression of UHRF1. Conversely, PDE1A re-expression counteracted the cellular pro-apoptotic effects of TQ in association with a p73 repression and UHRF1 re-expression. Altogether, our results show that TQ induced an initial down-regulation of PDE1A with a subsequent down-regulation of UHRF1 via a p73-dependent mechanism. This study further proposes that PDE1A might be involved in the epigenetic code inheritance by regulating, via p73, the epigenetic integrator UHRF1. Our findings also suggest that a forced inhibition of PDE1A expression might be a new therapeutic strategy for the management of acute lymphoblastic leukemia. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:152 / 160
页数:9
相关论文
共 54 条
[1]  
ABBADY AQ, 2005, BIOCHEM PHARMACOL, P570
[2]   TCR- and CD28-mediated recruitment of phosphodiesterase 4 to lipid rafts potentiates TCR signaling [J].
Abrahamsen, H ;
Baillie, G ;
Ngai, J ;
Vang, T ;
Nika, K ;
Ruppelt, A ;
Mustelin, T ;
Zaccolo, M ;
Houslay, M ;
Taskén, K .
JOURNAL OF IMMUNOLOGY, 2004, 173 (08) :4847-4858
[3]   The interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 is involved in the regulation of VEGF gene expression [J].
Achour, M. ;
Jacq, X. ;
Ronde, P. ;
Alhosin, M. ;
Charlot, C. ;
Chataigneau, T. ;
Jeanblanc, M. ;
Macaluso, M. ;
Giordano, A. ;
Hughes, A. D. ;
Schini-Kerth, V. B. ;
Bronner, C. .
ONCOGENE, 2008, 27 (15) :2187-2197
[4]   Induction of apoptosis by thymoquinone in lymphoblastic leukemia Jurkat cells is mediated by a p73-dependent pathway which targets the epigenetic integrator UHRF1 [J].
Alhosin, Mahmoud ;
Abusnina, Abdurazzag ;
Achour, Mayada ;
Sharif, Tanveer ;
Muller, Christian ;
Peluso, Jean ;
Chataigneau, Thierry ;
Lugnier, Claire ;
Schini-Kerth, Valerie B. ;
Bronner, Christian ;
Fuhrmann, Guy .
BIOCHEMICAL PHARMACOLOGY, 2010, 79 (09) :1251-1260
[5]   Recognition of hemi-methylated DNA by the SRA protein UHRF1 by a base-flipping mechanism [J].
Arita, Kyohei ;
Ariyoshi, Mariko ;
Tochio, Hidehito ;
Nakamura, Yusuke ;
Shirakawa, Masahiro .
NATURE, 2008, 455 (7214) :818-U12
[6]   Structural basis for recognition of hemi-methylated DNA by the SRA domain of human UHRF1 [J].
Avvakumov, George V. ;
Walker, John R. ;
Xue, Sheng ;
Li, Yanjun ;
Duan, Shili ;
Bronner, Christian ;
Arrowsmith, Cheryl H. ;
Dhe-Paganon, Sirano .
NATURE, 2008, 455 (7214) :822-U13
[7]   Sub-family selective actions in the ability of Erk2 MAP kinase to phosphorylate and regulate the activity of PDE4 cyclic AMP-specific phosphodiesterases [J].
Baillie, GS ;
MacKenzie, SJ ;
McPhee, I ;
Houslay, MD .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 (04) :811-819
[8]   FLAVONOID COMPOUNDS ARE POTENT INHIBITORS OF CYCLIC-AMP PHOSPHODIESTERASE [J].
BERETZ, A ;
ANTON, R ;
STOCLET, JC .
EXPERIENTIA, 1978, 34 (08) :1054-1055
[9]   UHRF1 plays a role in maintaining DNA methylation in mammalian cells [J].
Bostick, Magnolia ;
Kim, Jong Kyong ;
Esteve, Pierre-Olivier ;
Clark, Amander ;
Pradhan, Sriharsa ;
Jacobsen, Steven E. .
SCIENCE, 2007, 317 (5845) :1760-1764
[10]   The UHRF family: Oncogenes that are drugable targets for cancer therapy in the near future? [J].
Bronner, Christian ;
Achour, Mayada ;
Arima, Yoshimi ;
Chataigneau, Thierry ;
Saya, Hideyuki ;
Schini-Kerth, Valerie B. .
PHARMACOLOGY & THERAPEUTICS, 2007, 115 (03) :419-434